首页 | 官方网站   微博 | 高级检索  
     

肿瘤标志物CA19-9、CEA、CA242、CA125和AFP评估胃癌化疗疗效的检验分析
引用本文:施城东,樊卫.肿瘤标志物CA19-9、CEA、CA242、CA125和AFP评估胃癌化疗疗效的检验分析[J].国际检验医学杂志,2016(13):1777-1779.
作者姓名:施城东  樊卫
作者单位:江苏省淮安市淮安医院检验科 223200
基金项目:江苏省淮安市科学技术局支撑计划发展(社会发展)项目(HAS2012017)。
摘    要:目的探讨肿瘤标志物CA19-9、癌胚抗原(CEA)、CA242、CA125和甲胎蛋白(AFP)联合评估胃癌化疗疗效的检验分析。方法选取2010年1月至2013年12月该院收治的胃癌患者160例作为研究对象。分别检测患者治疗前和治疗后3个月相关肿瘤标志物的表达情况。并分析患者TNM分期与肿瘤标志物的关系,治疗前后肿瘤标志物的变化,复发转移与未复发转移患者体内肿瘤标志物的变化关系。结果不同TNM分期与相关肿瘤标志物的阳性表达率有显著相关性。Ⅲ期和Ⅳ期的患者相关肿瘤标志物的阳性表达率显著高于Ⅰ~Ⅱ期。患者经过化疗后CA19-9、CA242、CA125和AFP水平与治疗前相比均显著下降(P0.05),CEA水平治疗前后差异无统计学意义(P0.05)。经过治疗后,患者CEA、CA19-9、CA242、CA125以及AFP阳性表达率均下降,且与治疗前相比,差异有统计学意义(P0.05)。在复发转移患者与未复发转移患者血清相关肿瘤标志物的比较表明,复发转移患者的CEA、CA19-9、CA242、CA124和AFP水平均显著高于未复发转移组(P0.05)。结论 CA19-9、CEA、CA242、CA125和AFP与肿瘤患者TNM分期有着显著相关性,其表达水平以及阳性表达率与胃癌患者预后具有一定的相关性,值得临床重点关注。

关 键 词:肿瘤标志物  胃癌  疗效评价

Test analysis on tumor marker CA19-9,CEA,CA242,CA125 and AFP in assessing efficacy of chemotherapy in gastric cancer
Abstract:Objective To investigate the test analysis of tumor marker CA19‐9 ,CEA ,CA242 ,CA125 and AFP for jointly assess‐ing the chemotherapeutic effect of gastric cancer .Methods Totally 160 patients with gastric cancer in our hospital from January 2010 to December 2013 were selected as the research subjects .The expressions of related tumor markers were detected before treat‐ment and at 3 months after treatment .The relationship between the TNM staging and the tumor markers ,changes of tumor markers before and after treatment ,and changes of tumor markers in the patients with recurrence and metastasis ,and patients without recur‐rence and metastasis were analyzed .Results Different TNM staging had significant correlation with tumor markers associated posi‐tive expression rate .The positive expression rate of related tumor markers in the patients with stage Ⅲ and stage Ⅳ were signifi‐cantly higher than that in the patients with stage Ⅰ - Ⅱ .The positive expression rates of CA19‐9 ,CA242 ,CA125 and AFP after chemotherapy were significantly decreased compared with before treatment (P<0 .05) ,while the CEA level had no statistically sig‐nificant difference before and after treatment (P>0 .05) .After treatment ,the CEA ,CA19‐9 ,CA242 ,CA125 and AFP positive ex‐pression rates were declined ,moreover showing statistical differences compared with pre‐treatment (P<0 .05) .The CEA ,CA19‐9 , CA242 ,CA124 and AFP levels in the patients with recurrence and metastasis were significantly higher than those in the patients without recurrence and metastasis (P<0 .05) .Conclusion CA19‐9 ,CEA ,CA242 ,CA125 and AFP have a significant correlation with tumor TNM staging ,their expression level and positive expression rates have certain correlation with the prognosis in the pa‐tients with gastric cancer ,which is worthy of focus in clinic .
Keywords:tumor markers  gastric cancer  effect evaluation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号